Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 8:00 PM
Ignite Modification Date:
2025-12-24 @ 8:00 PM
NCT ID:
NCT03069404
Eligibility Criteria:
Inclusion Criteria:
* Must have undergone HuCNS-SC transplantation as a subject in the Phase I/II trial
* Must be able to provide written informed consent prior to any study related procedures
* Must agree to comply in good faith with all conditions of the study and to attend all required study visits
* Female subjects who are pregnant remain eligible for enrollment, but the MRI examination will not be performed during the pregnancy. Female subjects of child-bearing potential must have a negative urine pregnancy test prior to the MRI examination
Exclusion Criteria:
* Subjects have received or are receiving off-protocol immunosuppressive medications
* Subjects who after completion of CL-N02-SC have entered, or are about to enter any other interventional study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT03069404
Study Brief:
Protocol Section:
NCT03069404